-
January 2013 – Forbes
“How The U.S. Can Attract Biotech Firms by Imitating China”
View Article
-
February 2013 – simply-communicate.com
“It’s not always the size that counts in internal communication”
View Article
-
October 2012 – Nature Medicine
“Early-stage therapies target surgery-induced erectile dysfunction”
View Article
-
October 2012 – The Wall Street Journal
“How CEOs Improvised In the Wake Of Sandy”
Download PDF
-
September 2012 – Pharmaceutical Executive
“Upgrading the Tax Code to Bolster Biotech”
Download PDF
-
September 2012 – 914Inc.
“The County's Most Innovative Businesses”
Download PDF
-
June 2012 – TechReview
“Pill could reverse effects of a stroke long after it hits.”
Download PDF
-
April 2012 – Xconomy
“Five Questions: Acorda CEO Ron Cohen on the Future of Neurology R&D”
Download PDF
-
March 2012 – Pharmaceutical Executive
“FDA's Necessary Dose of Reality”
Download PDF
-
July 2011 – Xconomy
“Acorda Acquires Medtronic Drug, Fills Out Mid-Stage Neurology Pipeline”
Download PDF
-
May 2011 – The Scientist
“Best Places to Work in Industry, 2011”
Download PDF
-
March 2011 – Life Science Leader
“When Your Science Leads to an Unexpected Business Opportunity”
Download PDF
-
February 2011 – 914Inc.
“Westchester’s MedMen: The Classmates-Turned-Competitors Behind the County’s Biotech Boom”
Download PDF
-
November 2010 – InVivo
“Launching Acorda’s AMPYRA:The Long Road to Approval”
Download PDF